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Background: Previous studies in patients with hip and knee osteoarthritis (OA) have advocated the relevance of
assessing the number of painful joint sites, other than the primary affected joint, in both research and clinical
practice. However, it is unclear whether joint-pain comorbidities can simply be summed up.
Methods: A total of 401 patients with hip or knee OA completed questionnaires on demographic variables and
joint-pain comorbidities. Rasch analysis was performed to evaluate whether a sum score of joint-pain comorbidities
can be calculated.
Results: Self-reported joint-pain comorbidities showed a good fit to the Rasch model and were not biased by
gender, age, disease duration, BMI, or patient group. As a group, joint-pain comorbidities covered a reasonable
range of severity levels, although the sum score had rather low reliability levels suggesting it cannot discriminate
well among patients.
Conclusions: Joint-pain comorbidities, in other than the primary affected joints, can be summed into a joint pain
comorbidity score. Nevertheless, its use is discouraged for individual decision making purposes since its lacks
discriminative power in patients with minimal or extreme joint pain.
Keywords: Hip or knee osteoarthritis, Joint-pain comorbidities, Rasch analysis, Sum score, ValidityBackground
Previous studies in patients with hip and knee osteoarth-
ritis (OA) advocated the relevance of assessing the num-
ber of painful joints, other than the primary hip or knee
joint, in both research and clinical practice [1-3]. Joint-
pain comorbidities are related - both cross-sectionally
and longitudinally - to unfavourable health outcomes,
including a higher physical and psychological burden,
more severe fatigue, and worse health-related quality of
life [2,3].
To date, the use of joint counts to indicate the level of
joint-pain comorbidity in people with knee or hip OA is* Correspondence: L.siemons@utwente.nl
1Department of Psychology, Health & Technology, Arthritis Center Twente,
University of Twente, Enschede, The Netherlands
5Department of Psychology, Health & Technology, Faculty of Behavioural
Sciences, University of Twente, PO Box 217, 7500, AE, Enschede, the
Netherlands
Full list of author information is available at the end of the article
© 2013 Siemons et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orcommon [2-5]. By simply summing up the number of
joints that are indicated as painful for more than half of
the time during the last month, a fast and easy impression
of a patient’s overall degree of joint-pain comorbidities is
obtained. To determine painful joints, researchers often
use written questions or a manikin. Both methods are
deemed valid, although the use of a manikin is known to
result in a higher prevalence of musculoskeletal pain [6].
Remarkably, however, it remains unclear whether this sim-
ple summation of painful joints is actually justified. One
could make the argument that this is likely not the case,
as summing joints would mean that each of the joint
scores assess the same underlying construct and that all
joints are of equal importance (i.e. have equal weights) [7].
Therefore, the aim of this study was to examine the
validity of summing painful joint sites in people with hip
or knee OA.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Patients and measures
Data were used from a previous study, which examined
the prevalence of joint-pain comorbidities in patients with
a physician-based diagnosis of hip or knee OA [2]. The
patients were included if they were 18 years or older and
visited an orthopaedic surgeon at the Sint Maartenskliniek
(Netherlands) for a new episode of complaints due to hip
or knee OA (somewhere between June and October
2009). Patients concurrently suffering from an underlying
rheumatic disease were excluded.
At baseline, information was gathered on gender, age,
body-mass index (BMI), and disease duration. In addition,
the patients received a questionnaire within 14 days after
their visit, assessing their joint pain at 19 joint sites, in-
cluding the hands, wrists, elbows, shoulders, cervical
spine, thoracic spine, lumbar spine, hips, knees, ankles,
and feet. Patients had to indicate whether they experi-
enced symptoms from particular joints and whether these
symptoms were present for more than half of the time
during the last month. If both questions were positive, the
joint was counted as being painful.
The study was approved by the Institutional Review
Board of the University Medical Centre, Nijmegen and
all patients enrolled in the study gave informed consent.
Statistics
Rasch analysis
Whether the joint-pain comorbidities can simply be
summed up was evaluated using Rasch analysis. A fea-
ture of the Rasch model is that it assumes all items to be
equally discriminating [8]. As a result, a good fit between
the Rasch model and the data indicates that individual
joint scores can be summed up to obtain a total score of
joint-pain comorbidities during the past month [7].
In order to perform Rasch analysis, the data must con-
form to a number of underlying assumptions of the
Rasch model [8-10] including unidimensionality, model
fit, and local independence.
The first assumption, unidimensionality, was tested with
a principal component analysis of the tetrachoric correl-
ation matrix in SPSS Statistics 18.0, using oblimin rotation.
The scale was assumed to be sufficiently unidimen-
sional (i.e. there is one dominant underlying factor) if the
ratio of the first and second eigenvalue was >3 : 1 [11].
The second assumption concerns the model’s ability to
reflect the true relationship among the underlying con-
struct and the item responses [8-10]. This was tested by
evaluation of the mean square Infit (Infit MNSQ) and
mean square Outfit (Outfit MNSQ) fit statistics. Mean
square values show the ratio between the observed and
predicted variance, with an expected value of 1.0 [12].
Corrected for the sample size of 401 patients, the Infit and
Outfit ranges required for a good fit are 0.90-1.10 and0.70-1.30 respectively [13]. Higher values show unexpected
responses (noise) or might point to multidimensionality.
Lower values point to item redundancy, meaning that the
information provided by the item overlaps with the infor-
mation provided by other items [12,14,15].
The final assumption assumes that the items are not
further associated with each other once the Rasch factor
is taken into account. Violation of this assumption might
point to response dependency (e.g. overlapping items in
the scale) or to multidimensionality of the scale [9,12].
Items were assumed to be locally dependent if the re-
sidual correlation between two items was >0.5 [12].
In case the Rasch assumptions were satisfied, joints were
checked for differential item functioning (DIF). DIF is
present when subgroups of patients with similar levels of
the measured underlying construct (i.e. the degree of
joint-pain comorbidity as measured by summing the num-
ber of painful joints) give different responses (i.e. painful
or not painful) to a specific joint [9,10]. DIF was tested for
age, gender, BMI, disease duration, and patient group.
Subgroups of age (≤58 and >58) and disease duration
(≤10 years and >10 years) were created by splitting the
group at the median. BMI subgroups were created by
splitting the group at the BMI cut-off point for overweight
(BMI≥25). Patient groups were formed by separating the
knee OA patients from the hip OA patients. In case a pa-
tient experienced both knee as well as hip pain, the patient
was classified based on their primary complaint.
Finally, the performance of the sum score was examined
by evaluating its test information function with associated
reliability levels; showing whether precise and reliable
joint-pain comorbidity scores can be obtained across the
range of joint pain comorbidity severity. Reliabilities >0.7
were deemed acceptable for group use [9]. In addition, the
higher the test information, the better the test will be able
to discriminate among individuals [10].
Rasch analyses were performed using Winsteps, ver-
sion 3.65 (Winsteps, Chicago, IL, USA).
Results
Patients
Data were collected from 401 patients (58% [n=231]
women and 42% [n=170] men), of which 71% were re-
ferred for knee OA and 29% for hip OA. The average
(SD) age of the study sample was 58 (13) years, with an
average (SD) body mass index of 27 (5) kg/m2. The ma-
jority of the participants had a K/L grade of ≥ 2 and a
disease duration of >5 years, respectively 76% and 61%.
Mean (SD) pain levels were 45 (21) points for the hip
group and 50 (20) points for the knee group, as mea-
sured with the Hip disability and Osteoarthritis Out-
comes Score and Knee Injury and Osteoarthritis
Outcome Score respectively [16,17]. More detailed sam-
ple characteristics have been described elsewhere [2,18].
Table 1 Rasch fit statistics of all 19 items (N=401), with hip scores removed for hip patients and knee scores for knee
patients
Joint Measure Fit DIF
Logits Infit MNSQ Infit ZSTD Outfit MNSQ Outfit ZSTD Age Gender BMI Disease duration Patient group
Lumbar spine −2.02 1.23 3.5 1.28 2.3 −0.73 0.26 0.20 0.14 1.14
Left knee −1.45 1.24 1.8 1.21 1.0 1.03 1.12 0.45 −0.70 N/A
Right knee −1.11 1.02 0.2 1.06 0.3 −1.11 −0.31 0.30 −0.10 N/A
Neck −0.90 1.00 0.1 1.04 0.4 −0.17 0.02 −0.84 0.07 −0.11
Right shoulder −0.46 1.04 0.4 1.01 0.1 −0.17 −0.18 −0.16 0.11 0.04
Left shoulder −0.21 0.87 −1.2 0.72 −1.6 0.21 −0.32 −0.05 −0.06 −0.15
Right hand −0.10 0.95 −0.4 0.99 0.0 0.99 −0.53 −0.05 −0.23 −0.65
Left foot 0.06 0.94 −0.5 0.89 −0.4 0.19 −0.10 0.37 0.11 −0.45
Right hip 0.07 1.02 0.2 1.04 0.2 −0.16 0.03 0.17 0.59 N/A
Left hip 0.07 1.16 1.2 1.38 1.5 −0.84 −0.49 −0.30 0.45 N/A
Right foot 0.10 0.94 −0.5 0.77 −1.1 0.11 −0.03 −0.12 −0.46 0.08
Left hand 0.24 1.05 0.4 1.09 0.4 1.04 −0.26 −0.06 −0.28 −0.78
Thoracic spine 0.48 1.09 0.7 0.85 −0.5 −0.22 0.11 0.19 0.45 0.85
Right ankle 0.54 0.99 0.0 0.98 0.0 −0.53 0.19 −0.25 −0.60 0.69
Left ankle 0.59 0.89 −0.7 0.67 −1.3 −0.21 −0.77 0.10 −0.21 −0.69
Right wrist 0.65 0.79 −1.3 0.52 −1.9 0.38 −0.14 0.28 0.02 −0.62
Left wrist 0.71 0.87 −0.7 0.63 −1.3 1.08 −0.03 0.00 0.04 −0.19
Right elbow 1.11 1.09 0.5 1.33 0.9 −0.46 1.57 0.66 0.38 −0.99
Left elbow 1.65 0.95 −0.1 0.88 −0.1 −0.05 0.92 0.32 0.20 −1.02
Infit MNSQ: mean square Infit, Outfit MNSQ: mean square Outfit, ZSTD: standardized as a z-score, DIF: differential item functioning, BMI: body-mass index, N/A: not
available. Bold values show either Infit MNSQs or Outfit MNSQs outside their specified range or show the presence of differential item functioning (DIF). DIF would
have been significant when: p< (0.05/(5*19))= 0.000526 (corrected for sample size) AND when the absolute difference between the two difficulty parameters was
≥0.5 logits. However, no significant DIF results were found in this study.
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The test of unidimensionality showed that the ratio be-
tween the first and second eigenvalue was 9.701 : 2.117,
which is >3 : 1. Thus, the 19 items formed a sufficiently
unidimensional scale for Rasch analysis.
The results of the Rasch analysis showed an acceptable
fit of the comorbid joints (i.e. other than the primary af-
fected joints) to the Rasch model (Table 1). Infit MNSQFigure 1 Test information function of the 19 items, with hip scores re
associated reliability level (r) and standard error of measurement (SEM) are
score of 0). Higher values of ϴ indicate a higher number of painful joints. L
comorbidity scores of 1, 9-10, and 18, respectively.was <0.90 or >1.10 for 7 out of the 19 joints and Outfit
MNSQ was <0.70 or >1.30 for only 5 joints. Addition-
ally, none of the items showed DIF and local independ-
ence of the items was supported by low inter-item
residual correlations (<0.49).
Although some Infit and Outfit values fell outside the
specified range for a number of joints, these analyses
were based on very strict sample size corrected Infit andmoved for hip patients and knee scores for knee patients. Its
included and ϴ indicates the latent variable (standardized to a logit
ogit values of -3, 0, and 3 correspond approximately to total
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rule of thumb is that both the Infit and the Outfit
MNSQ are allowed to be somewhere between the 0.7
and 1.3. When these values were held against the data,
fit was even better with none of the joints showing Infit
MNSQ values <0.70 or >1.30 and only 5 joints showing
Outfit MNSQ values <0.70 or >1.30.
The test information function (Figure 1) shows that
joint-pain comorbidities covered a reasonable range of
joint-pain comorbidity levels. However, its measurement
reliability was relatively low with a maximum value of
0.76. Reliability was only above the minimally required
value for group use, r > 0.70, within a range of -1.04 to
+1.18, corresponding to the presence of 5 to 14 painful
joints. Although this indicates that the instrument can
discriminate well between patients within these wide
range of joint scores, it only covered 11.2% of the patient
sample since most patients (86.8%) had less than 5 pain-
ful joints. The instrument’s discriminative power for this
large majority of patients with few complaints is much
lower, diminishing the instrument’s usefulness.
Discussion
The past decades show a marked increase in item re-
sponse theory applications within the rheumatic field
[19]. Item response theory offers a powerful framework
for developing and evaluating patient-reported and clin-
ical measures, item banks, or computerized adaptive
tests. In addition, Rasch analysis can be used for examin-
ing the validity of a scoring algorithm like the summa-
tion of pain scores of individual joints. This study
confirms that joint-pain comorbidities, in other than the
primary affected joints, can be summed into a joint pain
comorbidity score, as frequently used in previous studies
in order to determine its association to patients’ health
states [2-4,20]. The absence of DIF across age, gender,
disease duration, BMI, and patient group indicates that
this measure can validly be used in research. However,
even though the analyses confirmed that the instrument
can measure a reasonable range of pain comorbidities,
the instrument’s reliability was rather low and it lacks
discriminative power in patients with minimal or ex-
treme joint pain. Therefore, its use is discouraged for in-
dividual decision making purposes in clinical practice.
Comorbidity is very common in people with OA
[21,22] and is linked to the burden of illness [23]. A bet-
ter understanding of comorbidity in OA patients might
enable us to define new strategies to manage the OA
symptoms. Joint pain comorbidity can play an important
role in OA since previous studies already demonstrated
that higher joint counts in people with OA are associ-
ated with less favorable health states [2,3] and worse
outcomes after total knee replacement surgery [4]. Now
that we demonstrated that joint counts can be validlyused in medical research concerning patients with hip
and/or knee OA, future studies should further explore
joint pain impact and perhaps its manageability [24].
Conclusions
The results of this study showed that it is valid to sum
the number of painful joint sites to assess joint-pain co-
morbidity in hip or knee osteoarthritis. However, pru-
dence is in order when using this instrument for
treatment decisions on an individual level.
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